Compare TONX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TONX | QSI |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.4M | 273.7M |
| IPO Year | N/A | N/A |
| Metric | TONX | QSI |
|---|---|---|
| Price | $3.06 | $1.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.88 |
| AVG Volume (30 Days) | 715.7K | ★ 5.1M |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 7.29 | N/A |
| Revenue | ★ $7,760,000.00 | $3,177,000.00 |
| Revenue This Year | $526.82 | N/A |
| Revenue Next Year | $45.45 | $159.68 |
| P/E Ratio | $0.42 | ★ N/A |
| Revenue Growth | ★ 3760.70 | 40.20 |
| 52 Week Low | $2.73 | $0.95 |
| 52 Week High | $29.77 | $5.77 |
| Indicator | TONX | QSI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 45.77 |
| Support Level | N/A | $1.26 |
| Resistance Level | N/A | $1.43 |
| Average True Range (ATR) | 0.00 | 0.10 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 80.00 |
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.